BDX — BCAL Diagnostics Share News
0.000.00%
Last trade - 00:00- AU$27.65m
- AU$32.98m
- AU$2.55m
Australia Stock Exchange release from BCAL DIAGNOSTICS : Recent Analysis Significantly Improves Commercial Prospects
Australia Stock Exchange release from BCAL DIAGNOSTICS : Appendix 4C Revised
Australia Stock Exchange release from BCAL DIAGNOSTICS : Becoming a substantial holder
Australia Stock Exchange release from BCAL DIAGNOSTICS : PRE_NR Ends: 08:35:50
Australia Stock Exchange release from BCAL DIAGNOSTICS : Quarterly Activities/Appendix 4C Cash Flow Report
Brief: BCAL Diagnostics Says John Hurrell Appointed Chief Executive Officer
Australia Stock Exchange release from BCAL DIAGNOSTICS : Dr John Hurrell Appointed Chief Executive Officer
Australia Stock Exchange release from BCAL DIAGNOSTICS : PRE_NR Ends: 08:32:11
Australia Stock Exchange release from BCAL DIAGNOSTICS : Application for quotation of securities - BDX
Australia Stock Exchange release from BCAL DIAGNOSTICS : Change In Directors Interest Notice - Correction
Australia Stock Exchange release from BCAL DIAGNOSTICS : Directors Change of Interest Notice X 2
Australia Stock Exchange release from BCAL DIAGNOSTICS : Results of Meeting
Australia Stock Exchange release from BCAL DIAGNOSTICS : Results of Meeting
Australia Stock Exchange release from BCAL DIAGNOSTICS : AGM Presentation
Australia Stock Exchange release from BCAL DIAGNOSTICS : Addendum to Appendix 4C
Australia Stock Exchange release from BCAL DIAGNOSTICS : PRE_NR Ends: 08:32:14
Australia Stock Exchange release from BCAL DIAGNOSTICS : Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test
Australia Stock Exchange release from BCAL DIAGNOSTICS : PRE_NR Ends: 09:29:21
Australia Stock Exchange release from BCAL DIAGNOSTICS : Quarterly Activities/Appendix 4C Cash Flow Report